| Type of Biological Sample |
Components / Analytes |
Examination Technique |
Examination Procedure |
Status |
| Hematology |
| | | NRL-HE-OP-006 | Active
|
| - Modified Westergren Manual technique
| NRL-HE-SOP-005 | Active
|
| - SEBIA/ Capillary electrphoresis
| NRL-HEME-SOP-43 | Active
|
| NRL-HEME-SOP-43 | Active
|
- Hgb fractionation with solubility
| NRL-HEME-SOP-43 | Active
|
| Immunology |
| | | NRL-AC-SOP-125 | Active
|
| | NRL-AC-SOP-121 | Active
|
| NRL-AC-SOP-118 | Active
|
| | NRL-AC-SOP-116 | Active
|
| | NRL-IMM-SOP-055 | Active
|
| - Multiplex Flow Immunoassay
| NRL-IMM-SOP-003 | Active
|
| | NRL-MIC-SOP-78 | Active
|
- Anti Deamidated Gliadin Abs IgA
| - Multiplexflow immunoassay
| NRL-IMM-SOP-026 | Active
|
- Anti Deamidated Gliadin Abs IgG
| NRL-IMM-SOP-027 | Active
|
- Anti Tissue Transglutaminase Abs IgA
| NRL-IMM-SOP-024 | Active
|
- Anti Tissue Transglutaminase Abs IgG
| NRL-IMM-SOP-025 | Active
|
- Anti Cardiolipin Antibodies IgG
| NRL-IMM-SOP-029 | Active
|
- Anti Cardiolipin Antibodies IgM
| NRL-IMM-SOP-030 | Active
|
- Anti Cardiolipin Antibodies IgA
| NRL-IMM-SOP-028 | Active
|
- Anti Beta-2-Glycoprotein-1 Abs IgA
| NRL-IMM-SOP-031 | Active
|
- Anti Beta-2-Glycoprotein-1 Abs, IgG
| NRL-IMM-SOP-032 | Active
|
- Anti Beta-2-Glycoprotein-1 Abs, IgM
| NRL-IMM-SOP-033 | Active
|
- Anti Glomerular Basement Membrane Abs
| NRL-IMM-SOP-048 | Active
|
| NRL-IMM-SOP-048 | Active
|
- Anti Proteinase Antibodies
| - Multiplexflow immune assay
| NRL-IMM-SOP-048 | Active
|
| | NRL-AC-SOP-076 | Active
|
- Anti TSH-Receptor Antibodies
| NRL-AC-SOP-115 | Active
|
| NRL-AC-SOP-075 | Active
|
| | | NRL-AC-SOP-118 | Active
|
- Immunoglobulin Free Light Chains, 24 hr Urine
| NRL-AC-SOP-118 | Active
|
| | NRL-AC-SOP-116 | Active
|
| Molecular Pathology |
| - Common Hereditary Cancers Panel (47 Genes)
| - Next Generation Sequencing (NGS)
| NRL-GNX-SOP-019/NRL-GNX-SOP-022 / NRL-GNX-SOP-023 / NRL-GNX-SOP-049/NRL-GNX-SOP-040/NRL-GNX-SOP-012 | Active
|
- Hereditary Breast Cancer Panel (14 Genes)
| NRL-GNX-SOP-019/NRL-GNX-SOP-022 / NRL-GNX-SOP-023 / NRL-GNX-SOP-049/NRL-GNX-SOP-040/NRL-GNX-SOP-012 | Active
|
- Hereditary Breast and Ovarian Cancer Syndrome Panel (BRCA1 and BRCA2 Gene Sequencing)
| NRL-GNX-SOP-019/NRL-GNX-SOP-022 / NRL-GNX-SOP-023 / NRL-GNX-SOP-049/NRL-GNX-SOP-040/NRL-GNX-SOP-012 | Active
|
- Beta-Thalassemia (HBB Sequencing)
| | NRL-GNX-SOP-008/NRL-GNX-SOP-009/NRL-GNX-SOP-013/NRL-GNX-SOP-010/NRL-GNX-SOP-011/NRL-GNX-SOP-012 | Active
|
- Beta-Thalassemia (HBB Deletion/Duplication)
| - Multiplex ligation- dependent probe amplification (MLPA)
| NRL-GNX-SOP-015 | Active
|
- Alpha- Thalassemia (HBA1 and HBA2 Sequencing)
| | NRL-GNX-SOP-007/NRL-GNX-SOP-009/NRL-GNX-SOP-013/NRL-GNX-SOP-010/NRL-GNX-SOP-011/NRL-GNX-SOP-012 | Active
|
- Alpha- Thalassemia (HBA1 and HBA2 Deletion/Duplication)
| - Multiplex ligation- dependent probe amplification (MLPA)
| NRL-GNX-SOP-014/NRL-GNX-SOP-009/NRL-GNX-SOP-013 | Active
|
- BRCA1, BRCA2 Deletion Duplication Analysis
| NRL-GNX-SOP-001. NRL- GNX-SOP-005. NRL-GNX- SOP-007. NRL-GNX-SOP- 008.NRL-GNX-SOP-
014NRL-GNX-SOP-015 | Active
|
- Sickle Cell Disease Genetic Analysis
| | NRL-GNX-SOP-005. NRL-
GNX-SOP-007.NRL-GNX- SOP-016 | Active
|
- Known Familial Variant Analysis (One Exon, Sequencing)
| NRL-GNX-SOP-013/NRL-GNX-SOP-010/NRL-GNX-SOP-011/NRL-GNX-SOP-012 | Active
|
- Known Familial Variant Analysis (Two Exons, Sequencing)
| NRL-GNX-SOP-013/NRL-GNX-SOP-010/NRL-GNX-SOP-011/NRL-GNX-SOP-012 | Active
|
- Alpha and Beta Thalassemia Known Familial Variant Analysis
| NRL-GNX-SOP-001. NRL- GNX-SOP-005. NRL-GNX- SOP-007. NRL-GNX-SOP-
008NRL-GNX-SOP-016 | Active
|
| Molecular Diagnostics |
| - BCR ABL1 p210, quant, blood
| - Real-time reverse transcription polymerase chain (RT-PCR)
| NRL-GNX-SOP-029/NRL-GNX-SOP-030 | Active
|
- BCR ABL1 p210, CML MRD, blood
| NRL-GNX-SOP-052 | Active
|
| NRL-GNX-SOP-037 | Active
|
| NRL-GNX-SOP-037 | Active
|
- BCR ABL1 p210 p190 p230, qual, blood
| NRL-GNX-SOP-042 | Active
|
| - BCR ABL1 p210, quant, marrow
| NRL-GNX-SOP-029/NRL-GNX-SOP-030 | Active
|
- JAK2 V617F, Quant, marrow
| NRL-GNX-SOP-037 | Active
|
| NRL-GNX-SOP-037 | Active
|
- BCR ABL1 p210 p190 p230, qual, marrow
| NRL-GNX-SOP-042 | Active
|
| - Factor V Leiden Mutation (R506Q)
| | NRL-MDL-SOP-035 version 1.0_Thrombosis SNP detection by Real-time PCR | Active
|
- Factor II Mutation (G20210A)
| NRL-MDL-SOP-035 version 1.0_Thrombosis SNP detection by Real-time PCR | Active
|
| NRL-MDL-SOP-035 version 1.0_Thrombosis SNP detection by Real-time PCR | Active
|
| | | NRL-MDL-SOP-032 version 1.0_HIV-1/HIV-2 QuaLItative by Real -Time PCR | Active
|
| NRL-MDL-SOP-032 version 1.0_HIV-1/HIV-2 Qualitative by Real -Time PCR | Active
|
- Cervical Cells in ThinPrep/SurePath
| | - Real-time PCR/Melting Curve
| NRL-MDL-SOP-036 version 1.0_HPV Genotyping by Real-Time PCR | Active
|
| - C.trachomatis & N.gonorrhoeaea
| NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR | Active
|
| NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR | Active
|
| NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR | Active
|
- U.urealyticum & M.hominis
| NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR | Active
|
| NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR | Active
|
| NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR | Active
|
| | | NRL-MDL-SOP-034 version 1.0_HBV Quantitative by Real -Time PCR | Active
|
| NRL-MDL-SOP-033 version 1.0_HCV Quantitative by Real -Time PCR | Active
|
| Molecular Genomics |
| - Influenza A, Influnza B, RSV
| | NRL-MDL-SOP-031 Detection of Influenza A, Influenza B, Respiratory Syncytial Virus ver.1.0 | Active
|
- Nasopharyngeal swab, Oropharyngeal swab, Sputum
| | NRL-MDL-SOP-026 2019 Novel Coronavirus (COVID-19) ver.007 | Active
|
| - B Lymphoblastic Leukemia/Lymphoma Diagnosis (BCR-ABLp190quantitative), Blood
| - Real-time reverse transcription polymerase chain (RT-PCR)
| NRL-GNX-SOP-061 | Active
|
- B Lymphoblastic Leukemia/Lymphoma Diagnosis (BCR-ABLp190quantitative), Bone marrow
| NRL-GNX-SOP-061 | Active
|
- Whole Exome Sequencing, proband only, blood
| - Next Generation Sequencing
| NRL-GNX-SOP-057 | Active
|
- Whole Exome Sequencing, Duo, blood
| NRL-GNX-SOP-057 | Active
|
- Whole Exome Sequencing, Trio, blood
| NRL-GNX-SOP-057 | Active
|
- Cardiomyopathy, NGS, blood
| NRL-GNX-SOP-057 | Active
|
- Familial Hypercholesterolemia, NGS, blood
| NRL-GNX-SOP-057 | Active
|
- Diabetes mellitus, monogenic, NGS, blood
| NRL-GNX-SOP-057 | Active
|
- Maturity onset diabetes of the young, MODY, NGS, blood
| NRL-GNX-SOP-057 | Active
|
- Retinitis Pigmentosa, NGS, blood
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Neuronal Migration Disorder (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Craniosynostosis syndromes (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Cardiomyopathy, dilated (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Primary ciliary dyskinesia (NGS)
| NRL-GNX-SOP-057 | Active
|
- Kartagener syndrome (NGS)
| NRL-GNX-SOP-057 | Active
|
- Ataxic polyneuropathies (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Epilepsy, metabolic (NGS)
| NRL-GNX-SOP-057 | Active
|
- Cornelia de Lange syndrome (NGS)
| NRL-GNX-SOP-057 | Active
|
- Diabetes mellitus, permanent neonatal (NGS)
| NRL-GNX-SOP-057 | Active
|
- Diabetes mellitus, monogenic (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Maturity onset diabetes of the young (MODY) NGS
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Ectodermal dysplasia (NGS)
| NRL-GNX-SOP-057 | Active
|
- Autosomal dominant retinitis pigmentosa (NGS)
| NRL-GNX-SOP-057 | Active
|
- Autosomal recessive retinitis pigmentosa (NGS)
| NRL-GNX-SOP-057 | Active
|
- Bardet-Biedl syndrome (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Retinitis Pigmentosa (NGS)
| NRL-GNX-SOP-057 | Active
|
- Familial hemophagocytic lymphohistiocytosis (NGS)
| NRL-GNX-SOP-057 | Active
|
- Autosomal dominant non-syndromic hearing loss (NGS)
| NRL-GNX-SOP-057 | Active
|
- Autosomal recessive non-syndromic hearing loss (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Spherocytosis, hereditary (NGS)
| NRL-GNX-SOP-057 | Active
|
- Ichthyosis and related disorders of cornification (NGS)
| NRL-GNX-SOP-057 | Active
|
- Ichthyosis, congenital (NGS)
| NRL-GNX-SOP-057 | Active
|
- Colorectal cancer, hereditary non-polyposis (NGS)
| NRL-GNX-SOP-057 | Active
|
- Congenital disorders of glycosylation (CDG) (NGS)
| NRL-GNX-SOP-057 | Active
|
- Disorders of sex development (DSD) (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Mitochondrial encephalopathy (NGS)
| NRL-GNX-SOP-057 | Active
|
- Lysosomal disorders (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Familial Hypoglycemia (NGS)
| NRL-GNX-SOP-057 | Active
|
- Growth Hormone Deficiency (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Hemolytic-uremic syndrome, atypical (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- X-linked mental retardation (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Limb-girdle muscular dystrophy (LGMD) (NGS)
| NRL-GNX-SOP-057 | Active
|
- Spinal Muscular Atrophy, Distal (NGS)
| NRL-GNX-SOP-057 | Active
|
- Muscular Dystrophies, Congenital (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Charcot-Marie-Tooth disease (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Noonan/CFC/Costello (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Periodic Fever Syndromes/Autoinflammation (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Osteogenesis imperfecta (NGS)
| NRL-GNX-SOP-057 | Active
|
- Micromelic Dysplasia (NGS)
| NRL-GNX-SOP-057 | Active
|
| NRL-GNX-SOP-057 | Active
|
- Ehlers-Danlos syndrome (NGS)
| NRL-GNX-SOP-057 | Active
|
- Spondylometaphyseal Dysplasia and Spondyloepiphyseal Dysplasia (NGS)
| NRL-GNX-SOP-057 | Active
|
- Waardenburg Syndrome (NGS)
| NRL-GNX-SOP-057 | Active
|
- Warburg-Micro Syndrome (NGS)
| NRL-GNX-SOP-057 | Active
|
- Wiskott-Aldrich syndrome (NGS)
| NRL-GNX-SOP-057 | Active
|
- Carrier Screening (NGS) - Basic
| NRL-GNX-SOP-057 | Active
|
- Carrier Screening (NGS) - Expanded
| NRL-GNX-SOP-057 | Active
|
- GeneticHealthScreen (NGS)
| NRL-GNX-SOP-057 | Active
|
- APOE genotyping, Alzheimer disease, blood
| | NRL-GNX-SOP-058 | Active
|
- JAK2 Exon 12 to 15, blood
| | NRL-GNX-SOP-031 | Active
|
| NRL-GNX-SOP-032 | Active
|
| NRL-GNX-SOP-033 | Active
|
- Acute Promyelocytic Leukemia (PML/RARA quantitative), Blood
| - Real-time reverse transcription polymerase chain (RT-PCR)
| NRL-GNX-SOP-042 | Active
|
- MPN ( JAK2, CALR, MPL, JAK2 E12, Blood)
| - Real-time reverse transcription polymerase chain (RT-PCR) and Sanger Sequencing
| NRL-GNX-SOP-052 /NRL-GNX-SOP-053/NRL-GNX-SOP-054/NRL-GNX-SOP-055 | Active
|
| - Real-time reverse transcription polymerase chain (RT-PCR)
| NRL-GNX-SOP-062 | Active
|
| - JAK2 Exon 12 to 15, marrow
| | NRL-GNX-SOP-031 | Active
|
| NRL-GNX-SOP-032 | Active
|
| NRL-GNX-SOP-033 | Active
|
- Acute Promyelocytic Leukemia (PML/RARA quantitative), Bone marrow
| - Real-time reverse transcription polymerase chain (RT-PCR)
| NRL-GNX-SOP-042 | Active
|
- MPN (JAK2, CALR, MPL, JAK2 E12, BM)
| - Real-time reverse transcription polymerase chain (RT-PCR) and Sanger Sequencing
| NRL-GNX-SOP-052/NRL-GNX-SOP-054/NRL-GNX-SOP-055 | Active
|
| - PND Whole Exome Sequencing, proband only, AF
| - Next Generation Sequencing
| NRL-GNX-SOP-057 | Active
|
- Amniotic fluid, Whole Blood
| - PND Whole Exome Sequencing, Duo, AF
| NRL-GNX-SOP-057 | Active
|
- PND Whole Exome Sequencing, Trio, AF
| NRL-GNX-SOP-057 | Active
|
| Molecular Microbiology |
| - SARS-CoV-2 Whole Genome Sequencing
| | NRL-GNX-SOP-026 | Active
|
| HLA & Transplant |
| - HLA A,B,C,DRB1345,DQ,DP Low Resolution
| - PCR reverse sequence specific oligonucleotide probes (rSSOP) with Luminex® flow technology
| NRL-HLA-SOP-003 | Active
|
| - HLA Panel Reactive Antibody Screen
| - One Lambda LabMixed with Luminex® flow technology
| NRL-HLA-SOP-005 | Active
|
- HLA Class I and II Antibody Identification
| - Solid Phase Single Antigen Bead (SAB) with Luminex® flow technology
| NRL-HLA-SOP-006 | Active
|
- ACD/ EDTA Whole Blood & Serum
| | | NRL-HLA-SOP-012 | Active
|
| NIPT |
| - Non Invasive Prenatal Screening (NGS) Basic without Fetal Sex
| - Next Generation Sequencing
| NRL-GNX-NIPT-SOP-016, NRL-GNX-NIPT-SOP-024 | Active
|
- Non Invasive Prenatal Screening (NGS) Basic with Fetal Sex
| NRL-GNX-NIPT-SOP-016, NRL-GNX-NIPT-SOP-024 | Active
|
- Non Invasive Prenatal Screening (NGS) Pro without Fetal Sex
| NRL-GNX-NIPT-SOP-016, NRL-GNX-NIPT-SOP-024 | Active
|
- Non Invasive Prenatal Screening (NGS) Pro with Fetal Sex
| NRL-GNX-NIPT-SOP-016, NRL-GNX-NIPT-SOP-024 | Active
|
| Biochemistry |
| | | NRL-CHEM-SOP-069 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-001 | Active
|
| - Colorimetric Assay (bromcresol green Complex )
| NRL-CHEM-SOP-004 | Active
|
| | NRL-CHEM-SOP-013 | Active
|
| | NRL-CHEM-SOP-040 | Active
|
| - Kinetic (with pyridoxal-5'- phosphate)
| NRL-CHEM-SOP-002 | Active
|
| | NRL-CHEM-SOP-016 | Active
|
- Angiotensin Converting Enzyme
| | NRL-CHEM-SOP-018 | Active
|
| | NRL-CHEM-SOP-024 | Active
|
| - Kinetic (rate of the NADH oxidation)
| NRL-CHEM-SOP-028 | Active
|
| - Electrochemiluminescence Immunoassay
| NRL-CHEM-SOP-029 | Active
|
| | NRL-CHEM-SOP-033 | Active
|
| NRL-CHEM-SOP-034 | Active
|
- Bilirubin, Total and Direct
| | NA | Active
|
| | NRL-CHEM-SOP-145 | Active
|
| - Colorimetric (calcium-o- CPC complex)
| NRL-CHEM-SOP-038 | Active
|
| | NRL-CHEM-SOP-043 | Active
|
| - Ion-Selective Electrode (indirect)
| NRL-CHEM-SOP-114 | Active
|
| | NRL-CHEM-SOP-046 | Active
|
| | NRL-CHEM-SOP-056 | Active
|
| - Electrochemiluminescence Immunoassay
| NRL-CHEM-SOP-047 | Active
|
| | NRL-CHEM-SOP-032 | Active
|
| | NRL-CHEM-SOP-050 | Active
|
| NRL-CHEM-SOP-051 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-053 | Active
|
| NRL-CHEM-SOP-036 | Active
|
| | NRL-CHEM-SOP-057 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-059 | Active
|
| NRL-CHEM-SOP-164 | Active
|
| | NRL-CHEM-SOP-063 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-064 | Active
|
| NRL-CHEM-SOP-068 | Active
|
- Free Triiodothyronine (FT3)
| NRL-CHEM-SOP-067 | Active
|
| NRL-CHEM-SOP-065 | Active
|
| | NRL-CHEM-SOP-070 | Active
|
| - Enzymatic reference method with hexokinase
| NRL-CHEM-SOP-073 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-089 | Active
|
| | NRL-CHEM-SOP-081 | Active
|
| | NRL-CHEM-SOP-086 | Active
|
| | NRL-CHEM-SOP-054 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-095 | Active
|
| | NRL-AC-SOP-119 | Active
|
| - Colorimetric (Transferrin‑Fe‑complex)
| NRL-CHEM-SOP-098 | Active
|
| - Enzymatic Colorimetri(L‑lactate to pyruvate)
| NRL-CHEM-SOP-100 | Active
|
| | NRL-CHEM-SOP-101 | Active
|
| | NRL-CHEM-SOP-103 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-106 | Active
|
| - Colorimetric method (with Chlorophosphonazo)
| NRL-CHEM-SOP-107 | Active
|
| - Colorimetric (phosphomolybdate formation) 1
| NRL-CHEM-SOP-113 | Active
|
| - Ion-Selective Electrode (indirect)
| NRL-CHEM-SOP-114 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-108 | Active
|
| NRL-CHEM-SOP-116 | Active
|
| NRL-CHEM-SOP-117 | Active
|
| | NRL-CHEM-SOP-123 | Active
|
- Sex Hormone Binding Globulin (SHBG)
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-127 | Active
|
| - Ion-Selective Electrode (indirect)
| NRL-CHEM-SOP-114 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-130 | Active
|
- Thyroid Stimulating Hormone (TSH)
| NRL-CHEM-SOP-134 | Active
|
| NRL-CHEM-SOP-135 | Active
|
| | NRL-CHEM-SOP-137 | Active
|
| | NRL-CHEM-SOP-138 | Active
|
| | NRL-CHEM-SOP-141 | Active
|
| - Enzymatic (Trinder Endpoint Reaction)
| NRL-CHEM-SOP-142 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-143 | Active
|
- Unsaturated Iron Binding Capacity
| | NRL-CHEM-SOP-161 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-149 | Active
|
| NRL-AC-SOP-117 | Active
|
| | NRL-AC-SOP-011 | Active
|
| - Enzymatic colorimetric (Uricase)
| NRL-CHEM-SOP-146 | Active
|
| | NRL-CHEM-SOP-062 | Active
|
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-096 | Active
|
| NRL-CHEM-SOP-037 | Active
|
| | NRL-CHEM-SOP-054 | Active
|
- Anti-Mullerian Hormone (AMH)
| - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-019 | Active
|
| | NRL-CHEM-SOP-027 | Active
|
| | NRL-AC-SOP-129 | Active
|
| NRL-AC-SOP-130 | Active
|
- Carbohydrate Deficient Transferrin (CDT)
| - Capillary electrophoresis
| NRL-AC-SOP-126 | Active
|
- Serum Protein Electrophoresis
| NRL-AC-SOP-105 | Active
|
| - Chemiluminescent Immunoassay (CLIA)
| NRL-IMM-SOP-084 | Active
|
| - Faecal Pancreatic Elastase
| NRL-IMM-SOP-082 | Active
|
| | - Electrochemiluminescence immunoassay
| NRL-CHEM-SOP-129 | Active
|
| | NRL-CHEM-SOP-064 | Active
|
| | | NRL-CHEM-SOP-073 | Active
|
| | NRL-CHEM-SOP-093 | Active
|
| | NRL-CHEM-SOP-138 | Active
|
| | NRL-CHEM-SOP-004 | Active
|
| | | NRL-CHEM-SOP-057 | Active
|
| - Ion-Selective Electrode (indirect)
| NRL-CHEM-SOP-114 | Active
|
| | NRL-CHEM-SOP-016 | Active
|
| - Colorimetric (calcium-o- CPC complex)
| NRL-CHEM-SOP-038 | Active
|
| - Enzymatic reference method with hexokinase
| NRL-CHEM-SOP-073 | Active
|
| - Colorimetric method (with Chlorophosphonazo)
| NRL-CHEM-SOP-107 | Active
|
| | NRL-CHEM-SOP-004 | Active
|
| - Colorimetric (phosphomolybdate formation)
| NRL-CHEM-SOP-113 | Active
|
| - Ion-Selective Electrode (indirect)
| NRL-CHEM-SOP-114 | Active
|
| NRL-CHEM-SOP-114 | Active
|
| | NRL-CHEM-SOP-145 | Active
|
| - Turbidimetric method with Benzethonium chloride
| NRL-CHEM-SOP-138 | Active
|
| - Enzymatic Colorimetric (Uricase)
| NRL-CHEM-SOP-146 | Active
|
| | NRL-CHEM-SOP-062 | Active
|
- Urine Drug Test - Qualitative
| - Immunoassay - (Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Marijuana, MDMA/XTC, Methadone, Methamphetamine, Morphine/ Opiate, Phencyclidine, Spice/K2c, Tramadol, Tricyclic Antidepressants) - Chromatographic Immuoassay (Alpha Scientific)
| NRL-CM-SOP-010 | Active
|
- Urine Protein Electrophoresis
| - Capillary electrophoresis
| NRL-AC-SOP-106 | Active
|
- CO2 of exhaled breath after intake of a substrate enriched with the stable isotope 13C
| - 13C-Urea H. Pylori Breath Test
| - Isotope Mass Ratio Spectrophotometer IMRS
| NRL-AC-SOP-122 | Active
|
- Faeces in extraction buffer tube
| - Faecal Immunochemical Test
| | NRL-IMM-SOP-074 | Active
|
| Newborn Screening |
| | | NRL-NBS-SOP-005 | Active
|
| NRL-NBS-SOP-007 | Active
|
| NRL-NBS-SOP-004 | Active
|
| NRL-NBS-SOP-008 | Active
|
| NRL-NBS-SOP-003 | Active
|
- Immuno Reactive Trypsinogen (IRT)
| NRL-NBS-SOP-009 | Active
|
| - High Performance Liquid Chromatography (HPLC)
| NRL-NBS-SOP-022 | Active
|
| - Flow injection Analysis Tandem Mass Spectrometry (LC/MS)
| NRL-NBS-SOP-002 | Active
|
| NRL-NBS-SOP-002 | Active
|
| | NRL-NBS-BCG-SOP-001 | Active
|
| | | NRL-NBS-SOP-023 | Active
|
| | | NRL-NBS-SOP-024 | Active
|
| NRL-NBS-SOP-024 | Active
|
| Serology |
| | - Electrochemiluminescence immunoassay -Roche Cobas e601
| NRL-IMM-SOP-020 | Active
|
| - Electrochemiluminescence immunoassay -Roche Cobas 8000 (e602)
| NRL-IMM-SOP-017 | Active
|
| - Electrochemiluminescence immunoassay -Roche Cobas Pro
| NRL-IMM-SOP-011 | Active
|
| - Electrochemiluminescence immunoassay -Roche Cobas e601
| NRL-IMM-SOP-043 | Active
|
| NRL-IMM-SOP-044 | Active
|
- HIV Combi - HIV 1/2 Antibody & p24 Antigen
| - Electrochemiluminescence immunoassay -Roche Cobas 8000 (e602)
| NRL-IMM-SOP-010 | Active
|
| - Electrochemiluminescence immunoassay -Roche Cobas e601
| NRL-IMM-SOP-004 | Active
|
| NRL-IMM-SOP-005 | Active
|
| NRL-IMM-SOP-007 | Active
|
| NRL-IMM-SOP-008 | Active
|
| NRL-IMM-SOP-006 | Active
|
| NRL-IMM-SOP-023 | Active
|
| NRL-IMM-SOP-021 | Active
|
| NRL-IMM-SOP-022 | Active
|
| - Multiplex Flow Immunoassay - BioRad Bioplex 2200
| NRL-IMM-SOP-001 | Active
|
| NRL-IMM-SOP-002 | Active
|
| NRL-IMM-SOP-001 | Active
|
| NRL-IMM-SOP-001 | Active
|
| NRL-IMM-SOP-002 | Active
|
| - Chemiluminescent Immunoassay Diasorin XL
| NRL-AC-SOP-091 | Active
|
- Mycoplasma pneumoniae IgM
| - Chemiluminescent Immunoassay - Diasorin XL
| NRL-IMM-SOP-036 | Active
|
- Rapid Plasma Reagin (RPR), Qualitative
| | NRL-CM-SOP-008 | Active
|
| - Chemiluminescent Immunoassay - Diasorin XL
| NRL-IMM-SOP-066 | Active
|
| NRL-IMM-SOP-065 | Active
|
| | NRL-IMM-SOP-067 | Active
|
| | NRL-IMM-SOP-067 | Active
|
- Helicobacter pylori Antibodies, IgA
| | NRL-IMM-SOP-068 | Active
|
- Helicobacter pylori Antibodies, IgG
| NRL-IMM-SOP-068 | Active
|
- Helicobacter pylori Antibodies, IgM
| | NRL-IMM-SOP-068 | Active
|
- HIV 1 and 2 antibody confirmation
| - Lateral Flow Immunochromographic - BioRad Geenius
| NRL-IMM-SOP-064 | Active
|
| - ELISA Standard E - Dynex DSX
| NRL-IMM-SOP-081 | Active
|
- Syphilis: Treponemal Antibodies
| - Chemiluminescent Immunoassay - COBAS 8000
| NRL-IMM-SOP-083 | Active
|
- Treponema pallidum Hemagglutination (TPHA)
| | NRL-IMM-SOP-084 | Active
|
| Microbiology |
| | - Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)
| NRL-MIC-SOP-02 | Active
|
| - Rapid immunochromatographic test
| NRL-MIC-SOP-80 | Active
|
- Clostridium difficile toxin A& B
| NRL-MIC-SOP-39 | Active
|
- Rota/adenoviruses antigen
| NRL-MIC-SOP-37 | Active
|
- Modified Acid Fast Stain for CRYPTOSPORIDIUM,
| - Modified Acid fast Stain, Microscopy
| NRL-MIC-SOP-50 | Active
|
| - pH strips visual colour change for numerical value
| NRL-MIC-SOP-83 | Active
|
- Sputum, fasting gastric aspirate, induced sputum, tissue, biopsy, bronchial aspirate (washings/lavage) skin, cerebrospinal fluid (CSF), body fluid, stool, wound, abscess (except blood and bone marrow)
| - Acid Fast (Mycobacteria) Smear
| - Concentration by NAOH- NALC, Stain (Auramine and/or Kinyoun) and Microscopy
| NRL-MIC-SOP-84 | Active
|
- Sputum, fasting gastric aspirate, induced sputum, tissue, biopsy, bronchial aspirate (washings/lavage), skin, cerebrospinal fluid (CSF), body fluid, stool, wound, abscess (except blood and bone marrow)
| - Acid Fast (Mycobacteria) isolation & Susceptibility- MGIT960; Identification of MPT64, (mycobacterial protein fraction secreted from MTbc cells)
| - Mycobacterial culture & sensitivity (MGIT™ 960 mycobacterial detection system); Rapid MGIT TBc identification test- chromatographic immunoassay,
| NRL-MIC-SOP- 86,87,88,89 | Active
|
| | - BacT/ALERT® 3D Microbial Detection System
| NRL-MIC-SOP-81 | Active
|
- Bacterial & Yeast growth on culture media
| - Organism ID by protein profiling
| - MALDI-TOF (Matrix Assisted Laser Desorption Ionization – Time of Flight) Mass Spectrometry
| NRL-MIC-SOP-139 | Active
|
| | - Conventional culture (if identification and/or
| NRL-MIC-SOP-28 | Active
|
- Swab, sputum, tissue, fluids, blood culture, CSF, various specimens
| | | NRL-MIC-SOP-06 | Active
|
| | - Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)
| NRL-MIC-SOP-04 | Active
|
- Organism (Gonococcous) isolation
| NRL-MIC-SOP-04 | Active
|
- Sputum,Tracheal Aspirate & Bronchial lavage
| | NRL-MIC-SOP-25 | Active
|
| | - Conventional culture (MRSA Chrom agar ) & identification in MALDI TOF
| NRL-MIC-SOP-26 | Active
|
| | - Conventional culture+ then instrumentation is MALDI TOF
| NRL-MIC-SOP-24 | Active
|
| - Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)
| NRL-MIC-SOP-57 | Active
|
| NRL-MIC-SOP-58 | Active
|
- Low vaginal swab, Rectovaginal swab, Vaginal secretions, Rectal swab
| - Group B streptococcus isolation
| - Conventional culture & identification in MALDI TOF
| NRL-MIC-SOP-03 | Active
|
- Swab from skin, superficial
| | - Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)
| NRL-MIC-SOP-59 | Active
|
- Female: vagina, cervix, Uterus, bartholingland secretions, clitoris
| NRL-MIC-SOP-04 | Active
|
- Male: urethra, penis, prostate, epididymis & semenUrethral Culture
| NRL-MIC-SOP-05 | Active
|
- Sputum, Tracheal Aspirate & Bronchial lavage
| NRL-MIC-SOP-25 | Active
|
- Swab with Transport Medium
| | NRL-MIC-SOP-60 | Active
|
| - Stool Analysis (Ova & Parasites, Colour, Consistency, WBC, RBC)
| - Stool (concentration and trichrome staining)
| NRL-MIC-SOP-35 | Active
|
- Female Cervical swab, Male Urethral swab or Male Urine
| | - Rapid immunochromatographic test
| NRL-MIC-SOP-61 | Active
|
- Nasal Wash, Nasopharyngeal Aspirate, Nasopharyngeal Swab and Nasal Swab
| | NRL-MIC-SOP-77 | Active
|
- Wound swab, deep, Tissue, Fluid (not CSF)
| | - Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)
| NRL-MIC-SOP-28 | Active
|
- Mouth, Nasal, Nasopharynx, & Sinuses (ethmoid, maxillary)
| NRL-MIC-SOP-23 | Active
|
| | - Conventional culture (Candida Chrom agar ) & identification in MALDI TOF
| NRL-MIC-SOP-145 | Active
|
| | - Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)
| NRL-MIC-SOP-01 | Active
|
| Clinical Pathology |
| | - Reflectance Spectrophotometer
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| | NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|
| NRL-CM-SOP-002 | Active
|